Cited by 59Fatty Acid Research and HealthNutritional Studies and DietAquaculture Nutrition and Growth

Dietary and Pharmacological Fatty Acids and Cardiovascular Health

Open access
Wu, Huaizhu, Xu, Lu, Ballantyne, Christie M·2020·The Journal of Clinical Endocrinology & Metabolism

Abstract

Context: The effects of dietary intake of different fatty acids and pharmacological use of fatty acids, specifically long-chain n-3 polyunsaturated fatty acids (LC n-3 PUFAs), on cardiovascular health and atherosclerotic cardiovascular disease (ASCVD) prevention have been examined in a large number of observational studies and clinical trials. This review summarizes recent data and discusses potential mechanisms. Evidence acquisition: The review is based on the authors’ knowledge of the field supplemented by a PubMed search using the terms seafood, fish oil, saturated fatty acids, omega-3 fatty acids, eicosapentaenoic acid, docosahexaenoic acid, polyunsaturated fatty acids, monounsaturated fatty acids, and ASCVD. Evidence synthesis: We mainly discuss the recent clinical trials that examine the effects of different types of dietary fatty acids and pharmacological use of n-3 PUFA products on ASCVD prevention and the potential mechanisms. Conclusions: While replacement of dietary saturated fat with unsaturated fat, polyunsaturated fat in particular, or intake of LC n-3 PUFA–rich seafood has generally shown benefit for ASCVD prevention and is recommended for cardiovascular benefits, data on effects of n-3 PUFA products on ASCVD health are inconsistent. However, recent clinical trials support benefits of prescription EPA in ASCVD prevention. n-3 PUFAs may contribute to ASCVD prevention through multiple mechanisms, including lowering plasma triglyceride levels, anti-inflammatory effects, antithrombotic effects, and effects on endothelial function.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/clinem/dgz174

Cites

168 of 168 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Multiple large studies of low-dose EPA/DHA mixtures with contemporary background therapy including statin have failed to show significant reduction in cardiovascular endpoints.

    “Multiple large studies conducted since then to examine the benefits of low-dose mixtures of EPA and DHA with more contemporary background therapy, including statin therapy, have failed to show any significant reduction in cardiovascular endpoints.”

    From 2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypertriglyceridemia (2021) · cites this paper as [20]

    The Conclusions report that multiple large trials of low-dose EPA/DHA mixtures, including ASCEND and VITAL, did not significantly reduce their primary cardiovascular endpoints; the trial table also shows substantial statin use in several studies. But the claim’s phrase “any significant reduction in cardiovascular endpoints” is too broad: the Conclusions report a modest, significant reduction in vascular death in ASCEND. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

3 of the 171 references couldn’t be matched to a known paper.

Research works printed but not linked: 4

  1. [2]2. U.S. Department of Health and Human Services, U.S. Department of Agriculture. 2015–2020 Dietary Guidelines for Americans,8th ed. https://health.gov/dietaryguidelines/2015/guidelines/. Accessed April 8, 2019. [Google Scholar]
  2. [3]3. US National Library of Medicine, National Center for Biotechnology Information. PubChem https://pubchem.ncbi.nlm.nih.gov. Accessed May 20, 2019. [Google Scholar]
  3. [54]54. Dietary Guidelines Advisory Committee. Scientific Report of the 2015 Dietary Guidelines Advisory Committee: Advisory Report to the Secretary of Health and Human Services and the Secretary of Agriculture. Washington, DC: U.S. Department of Agriculture, Agricultural Research Service; 2015. [Google Scholar]
  4. [138]138. Bosch J, Gerstein HC, Dagenais GR, et al. n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. N Engl J Med. 2012;367:309–318. [DOI] [PubMed] [Google Scholar]

Cited by

Sorted by citations

Authors
Wu, H., Xu, L., & Ballantyne, C. M.
Affiliations
  • Baylor College of Medicine (US)
  • Department of Medicine, Baylor College of Medicine , Houston, Texas
Corresponding author
Ballantyne, Christie M
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2019-11-03
Volume
105
Issue
4
Pages
1030-1045
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2985377277
Cited by
59
References
171
Citations by year
2026: 9 · 2025: 18 · 2024: 9 · 2023: 5 · 2022: 10 · 2021: 6 · 2020: 2
FWCI
0.61
Type
journal article
Language
en
Open access
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (R01 HL098839)
  • American Heart Association (AHA16GRNT30410012)
  • American Diabetes Association (1-17-IBS-082)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
  • Life Sciences › Agricultural and Biological Sciences › Aquatic Science › Aquaculture Nutrition and Growth
Keywords
n-3 long-chain polyunsaturated fatty acids, omega-3 fatty acids, eicosapentaenoic acid, docosahexaenoic acid, atherosclerotic cardiovascular disease prevention, cardiovascular health, dietary fatty acids, fish oil supplementation, saturated fatty acids, monounsaturated fatty acids, seafood, plasma triglycerides, anti-inflammatory activity, antithrombotic activity, endothelial function
MeSH terms
Cardiovascular Diseases, Fatty Acids, Humans, Prognosis, Dietary Supplements

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review